Home > Drugs A – Z > Iron Dextran (By injection)

Iron Dextran (By injection)

Treats anemia (lack of iron).

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

Iron dextran is an iron replacement product that is used to treat iron deficiency, such as anemia (not enough iron in the blood) or blood loss in patients with certain conditions (eg, hemophilia, gastrointestinal bleeding). Iron is a mineral that the body needs to produce red blood cells. When the body does not get enough iron, it cannot produce the number of normal red blood cells needed to keep… Read more
Brand names include
Dexferrum, Infed
Drug classes About this
Parenteral Mineral-Trace Mineral

What works? Research summarized

Evidence reviews

Interventions for treating restless legs syndrome in patients with chronic kidney disease

People with restless legs syndrome (RLS) have an irresistible urge to move their limbs to relieve themselves of unpleasant sensations. RLS is common in chronic kidney disease (CKD) patients, however the cause is unknown. Patients with RLS often have reduced quality of life and increased risk of developing heart disease.

Blood Transfusion

This guideline contains recommendations about general principles of blood transfusion, and applies to a range of conditions and different settings. It does not include recommendations relating to specific conditions and provides guidance on:

The role of iron in the management of chemotherapy‐induced anemia in cancer patients receiving erythropoiesis‐stimulating agents

Background: The current treatment of CIA is ESAs, which increase the production of red blood cells (erythropoiesis), and in some cases ESAs and iron. In some cases, strategies such as no therapy or wait and watch with clinical oversight and red blood cell transfusion may be safe and suitable options. We conducted a systematic review to evaluate the benefits and harms of iron in the management of CIA.

See all (14)

Summaries for consumers

Interventions for treating restless legs syndrome in patients with chronic kidney disease

People with restless legs syndrome (RLS) have an irresistible urge to move their limbs to relieve themselves of unpleasant sensations. RLS is common in chronic kidney disease (CKD) patients, however the cause is unknown. Patients with RLS often have reduced quality of life and increased risk of developing heart disease.

The role of iron in the management of chemotherapy‐induced anemia in cancer patients receiving erythropoiesis‐stimulating agents

Background: The current treatment of CIA is ESAs, which increase the production of red blood cells (erythropoiesis), and in some cases ESAs and iron. In some cases, strategies such as no therapy or wait and watch with clinical oversight and red blood cell transfusion may be safe and suitable options. We conducted a systematic review to evaluate the benefits and harms of iron in the management of CIA.

PubMed Health Blog...

read all...